Yongdong Hu

The National Clinical Research Center For Mental Disorders And Beijing Key Laboratory Of Mental Disorders
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Lipid metabolic dysregulation-induced neuroinflammation in the pathophysiology of major depressive disorder.

Lipid metabolic dysregulation-induced neuroinflammation in the pathophysiology of major depressive disorder.

Journal: Frontiers in immunology

Published: May 08, 2025

Development and Validation of a Screening Tool for Generalized Anxiety and Major Depressive Disorder in Patients with Chronic Obstructive Pulmonary Disease.

Development and Validation of a Screening Tool for Generalized Anxiety and Major Depressive Disorder in Patients with Chronic Obstructive Pulmonary Disease.

Journal: Lung

Published: July 17, 2024

Validation of the patient health questionnaire (PHQ)-9 and PHQ-2 in patients with COPD in China.

Validation of the patient health questionnaire (PHQ)-9 and PHQ-2 in patients with COPD in China.

Journal: BMC psychiatry

Published: April 20, 2024

Esketamine vs Midazolam in Boosting the Efficacy of Oral Antidepressants for Major Depressive Disorder: A Pilot Randomized Clinical Trial.

Esketamine vs Midazolam in Boosting the Efficacy of Oral Antidepressants for Major Depressive Disorder: A Pilot Randomized Clinical Trial.

Journal: JAMA network open

Published: August 14, 2023

Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study.

Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study.

Journal: Brain and behavior

Published: July 06, 2023

Association between depressive symptoms and prediabetes: NHANES 2007-2016 findings.

Association between depressive symptoms and prediabetes: NHANES 2007-2016 findings.

Journal: Journal of affective disorders

Published: May 27, 2023

Factors influencing the tendency of residual symptoms in patients with depressive disorders: a longitudinal study.

Factors influencing the tendency of residual symptoms in patients with depressive disorders: a longitudinal study.

Journal: BMC psychiatry

Published: April 23, 2023

Validation of the Generalized Anxiety Disorder-7 in patients with COPD: a cross-sectional study.

Validation of the Generalized Anxiety Disorder-7 in patients with COPD: a cross-sectional study.

Journal: BMC psychiatry

Published: March 13, 2023

Comparative efficacy of face-to-face and internet-based cognitive behavior therapy for generalized anxiety disorder: A meta-analysis of randomized controlled trial.

Comparative efficacy of face-to-face and internet-based cognitive behavior therapy for generalized anxiety disorder: A meta-analysis of randomized controlled trial.

Journal: Frontiers in psychiatry

Published: December 09, 2021

Correction: Tracking and Monitoring Mood Stability of Patients With Major Depressive Disorder by Machine Learning Models Using Passive Digital Data: Prospective Naturalistic Multicenter Study.

Correction: Tracking and Monitoring Mood Stability of Patients With Major Depressive Disorder by Machine Learning Models Using Passive Digital Data: Prospective Naturalistic Multicenter Study.

Journal: JMIR mHealth and uHealth

Published: May 19, 2021

Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China.

Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China.

Journal: Neuropsychiatric disease and treatment

Published: May 08, 2021

Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.

Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.

Journal: BMC psychiatry

Published: May 12, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026